Related Experiment Videos
[Sjögren's syndrome and multiple myeloma]
1Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Altalános Orvostudományi Kar, III. Belklinika.
Orvosi Hetilap
|October 12, 2000
Summary
Sjögren's syndrome patients show a higher incidence of myeloma. Early aggressive chemotherapy may improve outcomes for patients with coexisting myeloma and Sjögren's syndrome.
Area of Science:
- Rheumatology and Oncology
Background:
- Sjögren's syndrome is an autoimmune disorder.
- Multiple myeloma is a cancer of plasma cells.
Observation:
- Two cases of coexisting Sjögren's syndrome and multiple myeloma were studied.
- A higher incidence of myeloma was observed in Sjögren's syndrome patients compared to the general population.
Findings:
- Common pathogenetic factors may link Sjögren's syndrome and myeloma.
- One patient with coexisting conditions achieved a 4-year survival with complete remission.
- Aggressive chemotherapy was employed in the successful case.
Implications:
- The prognosis for myeloma coexisting with Sjögren's syndrome may differ from pure myeloma.
- Early, aggressive therapeutic intervention is suggested for myeloma in Sjögren's syndrome patients.